Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • mjrruby2000000 mjrruby2000000 Jun 27, 2013 1:21 PM Flag

    I Think the FDA is Right..........................

    Clearly, GSK has greater resources to manufacture and bring the drug to market. Also, the manufacturing of their backbone is much easier to manufacture than our morpholino. If, which I believe we are granted AA, isn't it a good thing if the boys are on GSK's drug, with all the side effects, while we are getting ready to launch, rather than progressively losing function. There is no doubt, when we are ready, their drug will be taken off the market since a new standard of care will be established. Their side effects will cause this to happen without a doubt.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
14.4031+0.6031(+4.37%)12:01 PMEDT